Eisai Russia

Eisai Russia is owned by Eisai.

Eisai is one of the...

• Nikkei 225;
• Topix.

Eisai is a company listed under the stock ticker 4523 (JP).

Eisai has a direct presence in 11 countries.

Eisai has 12 subsidiaries including EA Pharma, Eisai Americas and Eisai Australia.

They are in:

• Pharmaceuticals92%
• Biotechnology8%

View the org chart displaying its 2 main executives

Most searched biographies at Eisai Russia

• Olga Konopleva, General Manager
• Evgenia Bukharov, Medical Director

Create your alert
to follow the executive moves at Eisai Russia.

Eisai has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Eisai Russia

Social media about Eisai Russia

• Eisai Russia on Wikipedia, Google News & Yahoo Finance
• Eisai Russia on LinkedIn, Twitter & YouTube

Contact by email its executives including Olga Konopleva

Call Eisai Russia at +7 495...

View the org chart

Register to receive your alert

Report an error